Medically prescribed heroin is greater quantity cost-effective than methadone for treating all a~-term street heroin users, according to a recently made known study by researchers at Providence Health Care and the University of British Columbia.

The study, published in the Canadian Medical Association Journal (CMAJ), attributed greatest in number of the economic benefits to the thing done that recipients of medically prescribed heroin (diacetylmorphine) stayed in handling longer and spent less time in return to a former state than those receiving methadone. Both results are associated by reduced criminal activity and lower hale condition care costs.

Additionally, an individual in the diacetylmorphine assign places to was more likely to live longer than someone receiving methadone vindication therapy.

The findings were drawn from the North American Opiate Medication Initiative (NAOMI), a experimental knowledge of medically prescribed heroin that took area in Vancouver from 2005 to 2008, at the same time that well as administrative drug data from British Columbia. NAOMI was North America's primitive-ever clinical trial of prescribed heroin.

The researchers - led by Dr. Aslam Anis, director of the Centre in favor of Health Evaluation and Outcome Sciences (CHOS) at Providence Health Care and professor in UBC's School of Population and Public Health - used a require to be paid-effectiveness analysis to compare treatments upper a one-, five- and 10-year termination, as well as a lifetime horizon.

Those in the methadone therapy group generated an average lifetime societal cost of $1.14 million per human frame, while those in the diacetylmorphine clump generated a lesser cost of $1.09 very great number. The study considered treatment expenditures, estimated costs with regard to drug therapies and costs borne ~ dint of. the justice system.

"NAOMI demonstrated that heroin-assisted therapy is a other effective treatment option than MMT, excepting now, thanks to this study, we be possible to also confidently say that there are forcible economic benefits of using this medication," Dr. Anis says.

"The investigation I get most about heroin-assisted therapy is whether we be able to afford the increased direct costs of the method of treating," says co-author Dr. Martin Schechter, a CHOS scientist and professor at UBC's School of Population and Public Health. "What this study shows is that the greater degree appropriate question is whether we have power to afford not to."

The NAOMI study, which was also led by researchers from PHC, CHOS and UBC, was a randomized grief aimed at testing whether medically prescribed heroin was greater degree of effective than methadone therapy for individuals who were not publicly benefiting from conventional treatment.

The results, published in the New England Journal of Medicine, showed that patients treated through the prescribed heroin were more in a fair way to stay in treatment or absolve heroin altogether and more likely to bring to want their use of illegal drugs and other illegal activities than patients treated with parole methadone.